Dare Bioscience, Inc. — Director's Dealing 2015

Jun 30, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-06-26

Reporting Person: Carvajal Alejandra (VP, General Counsel)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.40	2024-10-08	Common Stock (55000)		Direct
Stock Option (Right to Buy)	$8.16	2025-02-05	Common Stock (43000)		Direct

Footnotes

F1: This option was granted October 8, 2015. The option vests as to 25% of the shares on the first anniversary of September 23, 2014 and as to an additional 1/48th of the original number of shares at the end of each month of continuous service thereafter.

F2: This option was granted on February 5, 2015. The option vests as to 2.08333% of the underlying shares monthly through February 5, 2019.